Editas Medicine (EDIT) Non Operating Income (2015 - 2025)

Editas Medicine (EDIT) has reported Non Operating Income for 11 consecutive years, with -$569000.0 the latest figure, recorded in Q3 2025.

• In Q3 2025, Non Operating Income fell 116.14% year-over-year to -$569000.0; the TTM figure through Sep 2025 stood at -$987000.0 (down 105.5% YoY), while the FY2024 annual figure was $14.1 million, down 11.92% from the prior year.
• Non Operating Income improved to -$569000.0 in Q3 2025 per EDIT's latest filing, from -$1.7 million in the prior quarter.
• Across five years, Non Operating Income topped out at $5.1 million in Q3 2023 and bottomed at -$1.7 million in Q2 2025.
• Historically, Non Operating Income has averaged $1.8 million across 5 years, with a median of $1.2 million in 2024.
• Annual changes were most pronounced in 2022 — Non Operating Income jumped 1456.32% — and 2025, when it tumbled 139.36%.
• Editas Medicine's Non Operating Income stood at $174000.0 in 2021, then surged by 1456.32% to $2.7 million in 2022, then soared by 87.89% to $5.1 million in 2023, then plunged by 76.45% to $1.2 million in 2024, then sank by 147.5% to -$569000.0 in 2025.
• Business Quant data shows EDIT's Non Operating Income at -$569000.0 in Q3 2025, -$1.7 million in Q2 2025, and $75000.0 in Q1 2025.